Enter the first few characters of Company and click 'Go'
GlaxoSmithKline Pharmaceuticals Ltd. Company Financial Ratios Analysis
(Rs in Cr.) |
Mar 31, 2023 |
Mar 31, 2022 |
Mar 31, 2021 |
Mar 31, 2020 |
Mar 31, 2019 |
|
PER SHARE RATIOS |
Adjusted EPS (Rs.) |
35.75 |
21.55 |
27.11 |
25.65 |
24.82 |
Adjusted Cash EPS (Rs.) |
39.63 |
25.57 |
31.75 |
30.53 |
27.69 |
Reported EPS (Rs.) |
35.88 |
99.79 |
21.11 |
6.50 |
25.11 |
Reported Cash EPS (Rs.) |
39.76 |
103.82 |
25.75 |
11.38 |
27.98 |
Dividend Per Share |
32.00 |
90.00 |
30.00 |
40.00 |
20.00 |
Operating Profit Per Share (Rs.) |
47.19 |
44.62 |
35.29 |
38.87 |
35.80 |
Book Value (Excl Rev Res) Per Share (Rs.) |
103.58 |
158.06 |
88.37 |
108.62 |
126.47 |
Book Value (Incl Rev Res) Per Share (Rs.) |
103.58 |
158.06 |
88.37 |
108.62 |
126.47 |
Net Operating Income Per Share (Rs.) |
189.86 |
189.93 |
172.40 |
190.35 |
184.68 |
Free Reserves Per Share (Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
PROFITABILITY RATIOS |
Operating Margin (%) |
24.85 |
23.49 |
20.46 |
20.41 |
19.38 |
Adjusted Cash Margin (%) |
20.23 |
13.15 |
17.74 |
15.66 |
14.52 |
Adjusted Return On Net Worth (%) |
34.51 |
13.63 |
30.67 |
23.61 |
19.62 |
Reported Return On Net Worth (%) |
34.63 |
63.13 |
23.88 |
5.98 |
19.85 |
Return On long Term Funds (%) |
47.59 |
28.52 |
42.03 |
35.50 |
30.77 |
|
LEVERAGE RATIOS |
Long Term Debt / Equity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Owners fund as % of total Source |
100.00 |
100.00 |
99.99 |
99.99 |
99.99 |
Fixed Assets Turnover Ratio |
1.45 |
1.54 |
1.75 |
1.62 |
1.48 |
|
LIQUIDITY RATIOS |
Current Ratio |
1.55 |
1.99 |
1.67 |
1.73 |
1.39 |
Current Ratio (Inc. ST Loans) |
1.55 |
1.99 |
1.67 |
1.73 |
1.39 |
Quick Ratio |
1.18 |
1.67 |
1.28 |
1.27 |
1.08 |
Fixed Assets Turnover Ratio |
1.45 |
1.54 |
1.75 |
1.62 |
1.48 |
|
PAYOUT RATIOS |
Dividend payout Ratio (Net Profit) |
226.37 |
28.89 |
155.35 |
175.79 |
62.55 |
Dividend payout Ratio (Cash Profit) |
226.37 |
28.89 |
155.35 |
175.79 |
62.55 |
Earning Retention Ratio |
-151.72 |
-39.23 |
-47.53 |
22.04 |
29.50 |
Cash Earnings Retention Ratio |
-127.07 |
-17.32 |
-25.97 |
34.50 |
36.80 |
|
COVERAGE RATIOS |
Adjusted Cash Flow Time Total Debt |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Financial Charges Coverage Ratio |
497.54 |
418.15 |
200.48 |
116.17 |
1,277.22 |
Fin. Charges Cov.Ratio (Post Tax) |
372.95 |
884.86 |
124.51 |
31.42 |
856.04 |
|
COMPONENT RATIOS |
Material Cost Component(% earnings) |
36.95 |
39.98 |
43.78 |
41.69 |
42.70 |
Selling Cost Component |
0.00 |
0.00 |
0.00 |
4.28 |
0.00 |
Exports as percent of Total Sales |
5.04 |
1.64 |
0.95 |
0.85 |
1.70 |
Import Comp. in Raw Mat. Consumed |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Long term assets / Total Assets |
0.26 |
0.16 |
0.12 |
0.28 |
0.36 |
Bonus Component In Equity Capital (%) |
74.01 |
74.01 |
74.01 |
74.01 |
74.01 |